Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Toni K. Choueiri,Piotr Tomczak,Se Hoon Park,Balaji Venugopal,Stefan Symeonides,Jaroslav Hajek,Thomas Ferguson,Yen-Hwa Chang,Jae Lyun Lee,Naomi Haas,Piotr Sawrycki,Naveed Sarwar,Marine Gross-Goupil,Antoine Thiery-Vuillemin,Mauricio Mahave,Go Kimura,Rodolfo F. Perini,Todd L. Saretsky,Rituparna Bhattacharya,Lei Xu,Thomas Powles The Oncologist（2023）
关键词
renal cell carcinoma,health-related quality of life,nephrectomy,pembrolizumab
AI 理解论文
溯源树
样例
